Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.

Rother KI, Spain LM, Wesley RA, Digon BJ 3rd, Baron A, Chen K, Nelson P, Dosch HM, Palmer JP, Brooks-Worrell B, Ring M, Harlan DM.

Diabetes Care. 2009 Dec;32(12):2251-7. doi: 10.2337/dc09-0773. Epub 2009 Oct 6.

2.

History of islet transplantation.

Digon BJ 3rd.

Curr Diab Rep. 2009 Aug;9(4):312-6. Review.

PMID:
19640345
3.

Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.

Liu EH, Digon BJ 3rd, Hirshberg B, Chang R, Wood BJ, Neeman Z, Kam A, Wesley RA, Polly SM, Hofmann RM, Rother KI, Harlan DM.

Diabetologia. 2009 Jul;52(7):1369-80. doi: 10.1007/s00125-009-1342-7. Epub 2009 May 6.

4.

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.

Hirshberg B, Rother KI, Digon BJ 3rd, Lee J, Gaglia JL, Hines K, Read EJ, Chang R, Wood BJ, Harlan DM.

Diabetes Care. 2003 Dec;26(12):3288-95.

PMID:
14633816
5.

Sirolimus-induced interstitial pneumonitis in an islet transplant recipient.

Digon BJ 3rd, Rother KI, Hirshberg B, Harlan DM.

Diabetes Care. 2003 Nov;26(11):3191. No abstract available.

PMID:
14578266

Supplemental Content

Loading ...
Support Center